Roche testing for coronavirus and flu simultaneously
The U.S. Food and Drug Administration has given the Basel-based life sciences company Roche authorization to use a test that simultaneously tests for the coronavirus and flu infections. Roche is also launching a rapid antigen test for coronavirus.
Roche has developed a testing process for the simultaneous qualitative detection and differentiation of SARS-CoV-2, Influenza A and Influenza B in patients. This can be done with a single sample. According to a press release, the U.S. Food and Drug Administration (FDA) has authorized Roche to use this test in laboratories with the relevant certification. It has done so through Emergency Use Authorization, which means final authorization and approval have not yet been granted.
“With the approaching flu season, this new test is particularly important as SARS-CoV-2 and influenza infections can hardly be differentiated by symptoms alone. Now, with a single test, healthcare professionals can confidently provide the right diagnosis and most effective treatment plan for their patients,” said Thomas Schinecker, CEO of Roche Diagnostics.
The test is carried out with Roche’s widely-available, fully-automated cobas 6800/8800 systems, which provide up to 96 results in just three hours. Roche is thereby expanding its portfolio to include solutions for the fight against COVID-19. As recently as 1 September, a rapid antigen test for coronavirus had been announced. It will be launched at the end of this month. Roche intends to apply to the FDA for Emergency Use Authorization for this test as well.
Share this article
You may also be interested in
How Moderna is growing in Switzerland
The number one rule in real estate is “Location, Location, Location.” The global biotech company Moderna found its location in...Read More
Sandoz decides on Basel for headquarters
Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected...Read More
VectivBio sold for approximately 1 billion dollars
The takeover of VectivBio is now being finalized: the Boston-based firm Ironwood Pharmaceuticals, which specializes in gastrointestinal medicine, has agreed...Read More
University of Basel and RocketVax present new Covid vaccine
Researchers from the University of Basel have developed a new concept for a Covid vaccine in collaboration with the biotech...Read More
Rami Swiss and Elbit Systems now manufacturing in Jura
The newly established company Rami Swiss has inaugurated a new production facility in Courtételle in the canton of Jura together...Read More
Basel to become Europe’s Silicon Valley of biotech
Silicon Valley is synonymous with technology and innovation, and home to dozens of Fortune 1000 companies and thousands of startups....Read More